Cita APA

Vardi, M., & Levy, A. P. (2012). Is it time to screen for the Haptoglobin genotype to assess the cardiovascular risk profile and vitamin E therapy responsiveness in patients with diabetes?

Chicago Style Citation

Vardi, Moshe, i Andrew P. Levy. Is It Time to Screen for the Haptoglobin Genotype to Assess the Cardiovascular Risk Profile and Vitamin E Therapy Responsiveness in Patients With Diabetes? 2012.

Cita MLA

Vardi, Moshe, i Andrew P. Levy. Is It Time to Screen for the Haptoglobin Genotype to Assess the Cardiovascular Risk Profile and Vitamin E Therapy Responsiveness in Patients With Diabetes? 2012.